372910 — Hancom Lifecare Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual income statement for Hancom Lifecare, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	151,842	121,140	100,120	112,780	104,776
Cost of Revenue
Gross Profit	57,978	27,949	19,885	23,739	29,134
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	113,124	116,439	110,546	111,661	97,287
Operating Profit	38,717	4,701	-10,426	1,119	7,489
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	32,335	5,594	13,236	1,625	9,082
Provision for Income Taxes
Net Income After Taxes	27,690	4,835	9,269	871	7,336
Minority Interest
Net Income Before Extraordinary Items
Net Income	27,690	4,835	9,204	825	7,375
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	27,690	4,835	9,204	825	7,375
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,002	149	556	40.6	264
Dividends per Share